Porter's Five Forces Analysis: Pharmacies in Wembley, WA (2026)
Strategique's Porter's Five Forces draws on live competitor intelligence and ABS demographic data for Wembley, WA. Use this analysis as a starting point — then run your free Strategique Score to see the full competitive landscape.
The takeaway
Wembley is a high-opportunity, moderate-rivalry market where the owner who enters first with a consultation-first, premium-margin positioning wins defensibly. Do not compete on price or script volume—7 competitors already do that poorly (Michael's Chemist's 2.9★ proves it). Lock in premium suppliers, build 40+ five-star reviews via medication reviews and vaccination services, and price 10–15% above generic competitors within 18 months before new capital enters. Timing is critical: move in the next 6 months to own the 'health advisor' niche before a well-funded chain claims it.
Considering opening here?
Wembley's opportunity score of Excellent-tier and moderate density (Strong-tier) signal this is an attractive but not saturated market. Pharmacy licensing barriers are high, but once a competitor commits capital, they operate indefinitely. Move now—build brand authority (reviews, local partnerships with GPs, wellness workshops) within 18 months. After that, a well-capitalized entrant (e.g., Chemist Warehouse, Priceline) can cannibalizes share within 6 months if you haven't established loyalty.
Already operating here?
Seven operators in a 19,102-population suburb means 2,729 potential customers per competitor—workable but not loose. Wembley Pharmacy's 4.9★ dominance across 48 reviews signals it owns the 'trusted advisor' positioning; Michael's Chemist's 2.9★ across 53 reviews proves low rating volume is a death sentence here. Counter-move: Stack 40+ five-star reviews within 12 months by systematizing consultation capture (vaccination records, medication reviews, skincare advice) before new entrants can claim the same service niche. Do not compete on script volume—compete on being the pharmacy that remembers customer health history and proactively recommends.
Five Forces Assessment
| Force | Intensity | Rationale |
|---|---|---|
| Competitive Rivalry | Moderate | Seven operators in a 19,102-population suburb means 2,729 potential customers per competitor—workable but not loose. Wembley Pharmacy's 4.9★ dominance across 48 reviews signals it owns the 'trusted advisor' positioning; Michael's Chemist's 2.9★ across 53 reviews proves low rating volume is a death sentence here. Counter-move: Stack 40+ five-star reviews within 12 months by systematizing consultation capture (vaccination records, medication reviews, skincare advice) before new entrants can claim the same service niche. Do not compete on script volume—compete on being the pharmacy that remembers customer health history and proactively recommends. |
| Supplier Power | Moderate | Wembley's median income ($2,012/week) creates demand for branded vitamins, premium skincare, and compounding services—not just generics. Pharmacy 777's compounding presence shows local clients value customization. Counter-move: Negotiate exclusive supply agreements with 2–3 premium skincare or supplement brands (Swisse, Blackmores, or independent compounders) before competitors lock them. Product stockouts lose high-margin repeat customers faster than low script pricing wins them. |
| Buyer Power | Low | At $2,012/week median household income (above WA average) with 3.77% unemployment, Wembley residents are not price-sensitive for health services. They seek convenience, expertise, and personalization—not discounts. They will pay $15–25 premiums for consultation services (medication reviews, vaccine advice) and premium OTC products. Counter-move: Price 10–15% above generic competitors on consultation-backed services (e.g., $45 comprehensive medication reviews vs. $30 elsewhere). Margin expansion is the play, not volume. |
| Threat of New Entrants | Very High | Wembley's opportunity score of Excellent-tier and moderate density (Strong-tier) signal this is an attractive but not saturated market. Pharmacy licensing barriers are high, but once a competitor commits capital, they operate indefinitely. Move now—build brand authority (reviews, local partnerships with GPs, wellness workshops) within 18 months. After that, a well-capitalized entrant (e.g., Chemist Warehouse, Priceline) can cannibalizes share within 6 months if you haven't established loyalty. |
| Threat of Substitutes | Moderate | Online pharmacy delivery (Amazon Pharmacy, Chemist Direct) and telehealth (GP-issued e-scripts) are real threats for script fulfillment. However, Wembley's income profile and aging population (implied by vaccination/medication review demand) value in-person consultation. Counter-move: Make the pharmacy a health hub—offer blood pressure monitoring, BMI assessments, diabetes screening, and vaccination in-store. Bundle these services with script dispensing. Substitutes win on convenience (delivery); you win on clinical value (advice + early detection). |
Wembley is a high-opportunity, moderate-rivalry market where the owner who enters first with a consultation-first, premium-margin positioning wins defensibly. Do not compete on price or script volume—7 competitors already do that poorly (Michael's Chemist's 2.9★ proves it). Lock in premium suppliers, build 40+ five-star reviews via medication reviews and vaccination services, and price 10–15% above generic competitors within 18 months before new capital enters. Timing is critical: move in the next 6 months to own the 'health advisor' niche before a well-funded chain claims it.
Frequently Asked Questions
Should I compete on script price against Wembley Pharmacy's 4.9★ dominance?
No. Wembley residents have $2,012/week median income and 3.77% unemployment—price is not their decision driver. Wembley Pharmacy already owns 'trusted' via reviews. Instead, differentiate on service depth: offer free comprehensive medication reviews (15 mins, worth $45) with every new customer, build a vaccination clinic schedule, and create a skincare consultation service. Price these at $40–50 and capture the health-advisory margin Wembley Pharmacy is leaving on the table.
What's the biggest competitive risk entering Wembley now?
Losing the review game in months 1–6. Michael's Chemist has 53 reviews at 2.9★—enough volume to appear in search results but toxic reputation. If you enter without a systematic review-generation plan (e.g., SMS after vaccination, follow-up emails post-consultation), you'll appear lower in local search than Michael's despite better quality. Counter: Offer $5 vouchers for verified Google reviews only for first 60 customers; target 40 five-star reviews by month 6. This locks you into top-3 search visibility before new entrants start.
How do I price consultation services in Wembley without looking like a rip-off?
Benchmark against Wembley's income and bundle with script dispensing. At $2,012/week, residents spend $1,800+ monthly on household essentials—they allocate another $200–400 on discretionary health (vitamins, skincare, services). Price a medication review at $45 (takes 15 mins, margin ~70%), vaccines at standard PBS rates + $20 consultation fee, and skincare consultations at $30 (no product required, but 60% will buy $50–80 in skincare after advice). These are not 'rip-offs'—they're value-adds that justify switching from a discount-focused competitor.
Your next step: See demand and capacity benchmarks
The Strategique Score combines competitor density, market opportunity and demographic fit into a single 0–100 rating — free, no signup needed.
See demand and capacity benchmarks →